Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-14 9:46 pm Sale |
2025-04-10 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,133,196 10.400% |
-350,000 (-1.89%) |
Filing History |
| 2024-11-06 5:45 pm Unchanged |
2024-11-04 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,483,196 11.400% |
0 (Unchanged) |
Filing History |
| 2024-10-24 08:57 am Sale |
2024-10-22 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,483,196 11.800% |
-423,180 (-2.24%) |
Filing History |
| 2024-06-24 7:56 pm Sale |
2024-06-21 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,906,376 12.300% |
-50,000 (-0.26%) |
Filing History |
| 2024-05-17 9:37 pm Unchanged |
2024-05-16 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 12.900% |
0 (Unchanged) |
Filing History |
| 2024-04-08 5:44 pm Unchanged |
2024-04-04 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 13.100% |
0 (Unchanged) |
Filing History |
| 2024-02-22 4:17 pm Purchase |
2024-02-13 | 13G | Renovaro Biosciences Inc. RENB |
Abildgaard Ole | 11,162,447 7.600% |
1,000,000 (+9.84%) |
Filing History |
| 2024-02-16 6:11 pm Unchanged |
2024-02-14 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 13.200% |
0 (Unchanged) |
Filing History |
| 2024-02-16 3:03 pm Purchase |
2024-02-13 | 13D | Renovaro Biosciences Inc. RENB |
Sindlev Rene | 14,945,971 10.280% |
14,945,971 (New Position) |
Filing History |
| 2024-01-24 4:08 pm Purchase |
2023-08-01 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 14,945,971 20.900% |
1,084,500 (+7.82%) |
Filing History |
| 2024-01-24 4:08 pm Purchase |
2023-06-26 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 13,861,471 23.300% |
2,830,191 (+25.66%) |
Filing History |
| 2024-01-24 4:07 pm Purchase |
2023-03-17 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 11,031,280 19.600% |
1,328,472 (+13.69%) |
Filing History |
| 2024-01-24 4:07 pm Purchase |
2021-09-24 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,702,808 18.600% |
17,557 (+0.18%) |
Filing History |
| 2024-01-24 4:06 pm Purchase |
2019-09-30 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,685,251 20.900% |
170,114 (+1.79%) |
Filing History |
| 2024-01-24 4:05 pm Purchase |
2018-12-27 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,515,137 24.200% |
94,268 (+1.00%) |
Filing History |
| 2024-01-24 4:05 pm Unchanged |
2018-02-16 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,420,869 23.200% |
0 (Unchanged) |
Filing History |
| 2024-01-24 4:04 pm Purchase |
2017-10-13 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,420,869 48.600% |
250,000 (+2.73%) |
Filing History |
| 2024-01-24 4:04 pm Purchase |
2017-04-21 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,170,869 51.400% |
8,100,000 (+756.40%) |
Filing History |
| 2024-01-24 4:03 pm Purchase |
2016-03-14 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 1,070,869 11.200% |
1,070,869 (New Position) |
Filing History |
| 2023-11-03 5:25 pm Unchanged |
2023-10-27 | 13D | Renovaro Biosciences Inc. RENB |
William Anderson Wittekind | 18,956,376 28.400% |
0 (Unchanged) |
Filing History |